Literature DB >> 8763840

Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.

A Halinska1, T Belej, P J O'Brien.   

Abstract

The group I aziridinylquinone anti-cancer agents mitomycin C, diaziquone or trenimon were much more cytotoxic to DT-diaphorase-enriched L5178Y/HBM10 lymphoblasts than parental L5178Y cells and caused little oxygen activation. Furthermore, inactivation of cellular DT-diaphorase prevented cytotoxicity whereas catalase did not affect cytotoxicity. This suggests that DT-diaphorase activated these agents and the hydroquinone formed mediated DNA alkylation, crosslinking and cytotoxicity. The group II quinone agents phenanthrenequinone, 2-amino-1, 4-naphthoquinoneimine or naphthazarin were also more cytotoxic to L5178Y/HBM10 cells than parental cells and caused considerable oxygen activation. Inactivation of DT-diaphorase, however, prevented both oxygen activation and cytotoxicity. Furthermore added catalase decreased cytotoxicity, whereas catalase inactivation enhanced cytotoxicity. This suggests that DT-diaphorase activated these agents and the hydroquinone formed caused extensive oxygen activation sufficient to cause DNA oxidative damage and cytotoxicity. The group III quinone agents menadione, 2,3-dimethoxy-1,4-naphthoquinone and 2,6-dimethoxy-benzoquinone, on the other hand, were more cytotoxic to the parental cells than L5178Y/HBM10 cells and caused less oxygen activation than group II agents. Furthermore, inactivation of DT-diaphorase enhanced cytotoxicity and prevented oxygen activation than group II agents. Oxygen activation was therefore also attributed to hydroquinone autoxidation. However catalase did not affect cytotoxicity towards parental cells. This suggests that DT-diaphorase detoxified group III quinones and that cytotoxicity may involve DNA oxidative damage by the semiquinone radicals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763840      PMCID: PMC2150036     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  27 in total

Review 1.  DT-diaphorase and cancer chemotherapy.

Authors:  R J Riley; P Workman
Journal:  Biochem Pharmacol       Date:  1992-04-15       Impact factor: 5.858

2.  Quinone-induced DNA single strand breaks in rat hepatocytes and human chronic myelogenous leukaemic K562 cells.

Authors:  W A Morgan; J A Hartley; G M Cohen
Journal:  Biochem Pharmacol       Date:  1992-07-22       Impact factor: 5.858

3.  Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.

Authors:  T Yoshida; H Tsuda
Journal:  Biochem Biophys Res Commun       Date:  1995-09-14       Impact factor: 3.575

Review 4.  Cellular pharmacology of quinone bioreductive alkylating agents.

Authors:  S Rockwell; A C Sartorelli; M Tomasz; K A Kennedy
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

5.  DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation.

Authors:  C Lind; P Hochstein; L Ernster
Journal:  Arch Biochem Biophys       Date:  1982-06       Impact factor: 4.013

6.  Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.

Authors:  H D Beall; R T Mulcahy; D Siegel; R D Traver; N W Gibson; D Ross
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

7.  Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens.

Authors:  I Dwivedy; P Devanesan; P Cremonesi; E Rogan; E Cavalieri
Journal:  Chem Res Toxicol       Date:  1992 Nov-Dec       Impact factor: 3.739

8.  Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.

Authors:  N W Gibson; J A Hartley; J Butler; D Siegel; D Ross
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

9.  Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.

Authors:  A M Malkinson; D Siegel; G L Forrest; A F Gazdar; H K Oie; D C Chan; P A Bunn; M Mabry; D J Dykes; S D Harrison
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

10.  Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.

Authors:  S S Pan; F Yu; C Hipsher
Journal:  Mol Pharmacol       Date:  1993-06       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.